Option Care Health’s (OPCH) “Outperform” Rating Reiterated at Barrington Research

Barrington Research restated their outperform rating on shares of Option Care Health (NASDAQ:OPCH) in a research note issued to investors on Wednesday morning,Benzinga reports. They currently have a $38.00 price objective on the stock. Barrington Research also issued estimates for Option Care Health’s FY2025 earnings at $1.50 EPS, Q1 2026 earnings at $0.36 EPS, Q2 2026 earnings at $0.41 EPS and Q3 2026 earnings at $0.43 EPS.

Several other analysts have also commented on OPCH. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and lifted their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. JMP Securities restated a “market outperform” rating and issued a $36.00 target price on shares of Option Care Health in a research report on Tuesday, April 22nd. JPMorgan Chase & Co. increased their price target on Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a report on Thursday, March 6th. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and boosted their price objective for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. Finally, UBS Group raised shares of Option Care Health from a “neutral” rating to a “buy” rating and increased their target price for the stock from $38.00 to $40.00 in a research note on Wednesday. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, Option Care Health currently has a consensus rating of “Moderate Buy” and an average target price of $35.50.

Option Care Health Stock Performance

NASDAQ OPCH opened at $32.95 on Wednesday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock’s fifty day moving average is $33.35 and its two-hundred day moving average is $28.85. The firm has a market capitalization of $5.41 billion, a P/E ratio of 27.69, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. Option Care Health has a fifty-two week low of $21.39 and a fifty-two week high of $35.53.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The firm had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.26 billion. During the same quarter in the previous year, the company posted $0.26 EPS. The company’s revenue was up 16.3% compared to the same quarter last year. On average, research analysts anticipate that Option Care Health will post 1.22 earnings per share for the current year.

Insider Activity at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company’s stock, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.64% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in OPCH. Murphy & Mullick Capital Management Corp purchased a new position in Option Care Health in the 4th quarter valued at approximately $26,000. UMB Bank n.a. raised its stake in shares of Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after acquiring an additional 346 shares in the last quarter. Signaturefd LLC boosted its holdings in Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after purchasing an additional 1,005 shares during the period. Bessemer Group Inc. grew its stake in Option Care Health by 62.3% during the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company’s stock worth $54,000 after purchasing an additional 599 shares in the last quarter. Finally, Quadrant Capital Group LLC increased its holdings in Option Care Health by 172.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock worth $40,000 after purchasing an additional 1,099 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.